Literature DB >> 15161657

Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.

Raymond Lai1, George Z Rassidakis, L Jeffrey Medeiros, Latha Ramdas, Andre H Goy, Cathy Cutler, Yasushi Fujio, Keita Kunisada, Hesham M Amin, Frederic Gilles.   

Abstract

The tissue inhibitor of metalloproteinase-1 (TIMP1) is expressed in a subset of malignant lymphomas and can inhibit tumor spread and promote cell survival. Recent data suggest that TIMP1 expression may be regulated by signal transducer and activator of transcription (STAT)-3. Thus, we tested the hypothesis that TIMP1 expression is related to STAT3 activation in lymphomas, with a focus on anaplastic large cell lymphomas (ALCLs), which are known to express high levels of phosphorylated/active STAT3 (pSTAT3). Specific inhibition of STAT3 with a dominant-negative construct led to concentration-dependent down-regulation of TIMP1 expression in two anaplastic lymphoma kinase (ALK)(+) ALCL cell lines, Karpas 299 and SU-DHL-1. Using cDNA microarrays, ALK(+) ALCL cell lines consistently expressed the highest TIMP1 level among 29 lymphoma cell lines of various subtypes. The association between TIMP1 expression and high level of STAT3 activation was validated by Western blots and immunostaining using antibodies specific for pSTAT3 and TIMP1. We further evaluated the relationship between TIMP1 expression and STAT3 activation in 43 ALCL tumors (19 ALK(+) and 24 ALK(-)) using immunohistochemistry and a tissue microarray. The TIMP1(+) group had a mean of 64% pSTAT3(+) cells as compared to 23% pSTAT3(+) cells in the TIMP1(-) group (P = 0.002). As expected, TIMP1 positivity was higher in the ALK(+) group (15 of 19, 79%) compared with the ALK(-) group (5 of 24, 21%; P = 0.0002) because NPM-ALK restricted to ALK(+) tumors was previously shown to activate STAT3. In conclusion, STAT3 directly contributes to the high level of TIMP1 expression in ALK(+) ALCL, and TIMP1 expression correlates with high level of STAT3 activation in ALCL. TIMP1, as a downstream target of STAT3, may mediate the anti-apoptotic effects of STAT3.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15161657      PMCID: PMC1615762          DOI: 10.1016/S0002-9440(10)63781-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

1.  Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cell differentiation and lymphomagenesis.

Authors:  L Guedez; A Mansoor; B Birkedal-Hansen; M S Lim; P Fukushima; D Venzon; W G Stetler-Stevenson; M Stetler-Stevenson
Journal:  Blood       Date:  2001-03-15       Impact factor: 22.113

2.  Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells.

Authors:  G Li; R Fridman; H R Kim
Journal:  Cancer Res       Date:  1999-12-15       Impact factor: 12.701

Review 3.  STATs in oncogenesis.

Authors:  T Bowman; R Garcia; J Turkson; R Jove
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

4.  Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells.

Authors:  M Stetler-Stevenson; A Mansoor; M Lim; P Fukushima; J Kehrl; G Marti; K Ptaszynski; J Wang; W G Stetler-Stevenson
Journal:  Blood       Date:  1997-03-01       Impact factor: 22.113

5.  Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo.

Authors:  J R Grandis; S D Drenning; Q Zeng; S C Watkins; M F Melhem; S Endo; D E Johnson; L Huang; Y He; J D Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

6.  IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes.

Authors:  S Lacraz; L P Nicod; R Chicheportiche; H G Welgus; J M Dayer
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

7.  Tax proteins of human T-cell leukemia virus type 1 and 2 induce expression of the gene encoding erythroid-potentiating activity (tissue inhibitor of metalloproteinases-1, TIMP-1).

Authors:  M Uchijima; H Sato; M Fujii; M Seiki
Journal:  J Biol Chem       Date:  1994-05-27       Impact factor: 5.157

8.  Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter.

Authors:  M Bugno; L Graeve; P Gatsios; A Koj; P C Heinrich; J Travis; T Kordula
Journal:  Nucleic Acids Res       Date:  1995-12-25       Impact factor: 16.971

9.  STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients.

Authors:  V Gouilleux-Gruart; F Gouilleux; C Desaint; J F Claisse; J C Capiod; J Delobel; R Weber-Nordt; I Dusanter-Fourt; F Dreyfus; B Groner; L Prin
Journal:  Blood       Date:  1996-03-01       Impact factor: 22.113

10.  Principal components analysis to summarize microarray experiments: application to sporulation time series.

Authors:  S Raychaudhuri; J M Stuart; R B Altman
Journal:  Pac Symp Biocomput       Date:  2000
View more
  4 in total

1.  Signal transducers and activators of transcription-3 up-regulates tissue inhibitor of metalloproteinase-1 expression and decreases invasiveness of breast cancer.

Authors:  Jennifer Dien; Hesham M Amin; Neil Chiu; Winson Wong; Christine Frantz; Brian Chiu; John R Mackey; Raymond Lai
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

2.  Matrix metalloproteinases and tissue inhibitor of metalloproteinases are essential for the inflammatory response in cancer cells.

Authors:  Jun Sun
Journal:  J Signal Transduct       Date:  2010-07-20

3.  Parthenolide Relieves Pain and Promotes M2 Microglia/Macrophage Polarization in Rat Model of Neuropathy.

Authors:  Katarzyna Popiolek-Barczyk; Natalia Kolosowska; Anna Piotrowska; Wioletta Makuch; Ewelina Rojewska; Agnieszka M Jurga; Dominika Pilat; Joanna Mika
Journal:  Neural Plast       Date:  2015-05-18       Impact factor: 3.599

4.  NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases.

Authors:  Joel D Pearson; Jason K H Lee; Julinor T C Bacani; Raymond Lai; Robert J Ingham
Journal:  J Signal Transduct       Date:  2012-07-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.